ATMOFIN-S Tablets

Composition
  • Each Enteric Coated Tablet Contains:
  • Diclofenac Potassium BP
    50 mg
  • Serratiopeptidase IP
    10 mg

Packing
  • 10x10
    (Alu Alu)
MRP
  • 59

Overview

Diclofenac Potassium is a non-steroidal anti-inflammatory agent (NSAIDs) with antipyretic and analgesic actions.
Serratiopeptidase is a proteolytic enzyme (protease) produced by enterobacterium Serratia sp. E-15 used in the prevention of pain and swelling.

Indications

  • For the treatment of primary dysmenorrhea.
  • For the treatment of mild to moderate pain.
  • For the relief from the signs and symptoms of osteoarthritis.
  • For the relief from the signs and symptoms of rheumatoid arthritis.
  • Chronic inflammation.
  • Headaches, muscle and joint pain
  • Serious diseases like cancer and heart disease.
  • Superficial thrombophlebitis.
  • Postoperative & traumatic swelling.
  • Acute or chronic ear, nose or throat disorder

Rationale of Combination

Diclofenac Potassium is used as an anti-inflammatory agent to pacify mild to moderate pain and inflammation. Common conditions associated with pain and inflammation include arthritis, trauma, surgery and fibermyalgia. Additionally, serratiopeptidase helps to reduce fluid retention in affected areas, which contributes to proper drainage and a quicker recovery.

Contraindications

Diclofenac sodium + Serratiopeptidase is contraindicated in patients with active GI bleeding or perforations, asthma, renal or hepatic disorders, hypertension, porphyria, peri-operative pain in CABG surgery patients and bleeding disorders.

Side Effects

Skin rash
Diarrhea
Gastrointestinal disturbance
Nose bleed
Dizziness

Pharmacology

Diclofenac Potassium
Diclofenac Potassium is an acetic acid non-steroidal anti-inflammatory drug (NSAIDs) with analgesic and antipyretic properties. Diclofenac Potassium inhibits the production of prostaglandins by inhibiting COX-1 and COX-2 pathways thereby exhibiting anti- inflammatory effects.

Pharmacokinetics

Absorption: Well absorbed following oral administration.
Distribution: widely distributed in animals. Plasma protein binding exhibited is >99%.
Elimination: hepatic metabolism leads to elimination through urine.

Serratiopeptidase
Serratiopeptidase is an enzyme isolated from a non-pathogenic bacteria called enterobacteria Serratia E15. Serratiopeptidase has powerful anti-inflammatory properties and is particularly useful for post-traumatic swelling, fibrocystic breast disease and bronchitis. It is able to digest dead tissue, blood clots, cysts, and arterial plaques.

Other Interactions: Diclofenac potassium + Serratiopeptidase should be taken with food. Take the drug immediately after meals to avoid GI disturbances.

Interactions

Diclofenac potassium+ Serratiopeptidase should not be taken concomitantly with other NSAIDs, anticoagulants including low-dose/LMW heparin, sucralfate, triamterene, cyclosporine, cholestyramine, colestipol, digoxin, aspirin, methotrexate and lithium.